Harvard Bioscience, Inc. (HBIO) Q3 EPS Drops to 5c; Revs Flat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $8.35 +0.36%
Revenue Growth %: +6.1%
Financial Fact:
Net Income: -1.64M
Today's EPS Names:
OMID, SICP, SCKT, More
Revenue Growth %: +6.1%
Financial Fact:
Net Income: -1.64M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q3 EPS of $0.05, versus $0.08 reported last year. Revenue for the quarter came in at $26.38 million, versus $26.45 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ET
- FirstEnergy (FE) Tops Q3 EPS by 7c; offers guidance
- Zurn Water Solutions Corporation (ZWS) Tops Q3 EPS by 2c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
